Epidural Anesthesia With Chloroprocaine Versus Lidocaine

Sponsor
Jinling Hospital, China (Other)
Overall Status
Completed
CT.gov ID
NCT02287870
Collaborator
(none)
120
2
5

Study Details

Study Description

Brief Summary

Chinese made chloroprocaine has a rapid onset time, effective methodology, can last for a short time, provides fast motor recovery and causes no significant side effects.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Chloroprocaine hydrochloride is the chloridized local anesthetic of procaine hydrochloride, with twice the anesthetic intensity, four to five times the metabolization and half the side effect of procaine. The chloroprocaine hydrochloride product made in China has been on sale since 2002. To determine the clinical efficacy of low-epidural anesthesia with chloroprocaine versus lidocaine, the investigators carried out a prospective, randomized, double-blinded multi-centre clinical trial. The results demonstrate that epidural anesthesia using chloroprocaine has a more rapid onset time and shorter duration than with lidocaine. It can also provide a reliable sensory and motor block in epidural anesthesia, and is thus a more attractive alternative than lidocaine for middle and short duration surgical procedures.

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Official Title:
Low Epidural Anesthesia With Chloroprocaine Versus Lidocaine: a Prospective, Randomized, Double-blinded Multi-centre Clinical Trial in China
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Apr 1, 2008
Actual Study Completion Date :
Jun 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chloroprocaine Group

Epidural anesthesia with 3% chloroprocaine.

Drug: Chloroprocaine
60 patients undergoing lower limb or lower abdominal surgery from three hospitals in China received 3% chloroprocaine.
Other Names:
  • Chloroprocaine Hydrochloride
  • Active Comparator: Lidocaine Group

    Epidural anesthesia with 2% lidocaine.

    Drug: Lidocaine
    60 patients undergoing lower limb or lower abdominal surgery from three hospitals in China received 2% lidocaine.
    Other Names:
  • Lidocaine Hydrochloride
  • Outcome Measures

    Primary Outcome Measures

    1. Epidural anesthesia effects of chloroprocaine versus lidocaine [Four months (January - April, 2008)]

      The effects of epidural anesthesia are assessed by onset time of epidural block, pain free and recovery time, the upper block level and time, the degree of muscle relaxation, and motor recovery time.

    Secondary Outcome Measures

    1. Comparison of vital signs between chloroprocaine and lidocaine groups [Four months (January - April, 2008)]

      The vital signs are assessed by diastolic blood pressure (DBP), systolic blood pressure (SBP), and pulse oxygen saturation (SpO2).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Weight no more than 80 Kg or not more than 20% of normal weight

    • American Society of Anesthesiologists (ASA) grade I or II

    • No obstacles in thinking or language communication

    • No epidural puncture contraindications such as disturbances of blood coagulation, local infection of the puncture site or use of anticoagulants

    Exclusion Criteria:
    • Chronic obstructive pulmonary diseases

    • Serious heart, liver, renal and metabolic diseases

    • Cerebral thrombosis and sequela

    • Serious dehydration and electrolyte imbalance

    • Neuromuscular diseases

    • Pregnant or parturient women

    • Abnormal liver and kidney function

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Jinling Hospital, China

    Investigators

    • Study Director: Weiyan Li, M.D., School of Medicine, Nanjing University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Haibin Dai, Attending Doctor of Department of Anesthesiology, Jinling Hospital, China
    ClinicalTrials.gov Identifier:
    NCT02287870
    Other Study ID Numbers:
    • 2007NLY-004
    First Posted:
    Nov 11, 2014
    Last Update Posted:
    Nov 11, 2014
    Last Verified:
    Nov 1, 2014
    Keywords provided by Haibin Dai, Attending Doctor of Department of Anesthesiology, Jinling Hospital, China
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 11, 2014